Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Daniel Drucker [Biomarker April 2023] Can GLP-1/GIP therapies improve long term health outcomes
CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: A meta-analysis
Patel, Anuradha P
2021;12:721198 Ethics declarations Competing interests The authors declare no competing interests
In patients who do not respond to diet modifications, pharmacotherapy is advocated, and the use of acarbose is supported (statements 49 and 50), especially for late dumping syndrome
US$ 27.34
US$ 29.84
US$ 20.64
US$ 22.32
US$ 21.86
US$ 21.38
US$ 21.76
US$ 22.17
US$ 22.57
